Watch CBS News

Turing Pharmaceuticals CEO defends Daraprim price hike

When Turing Pharmaceuticals bought a 62-year-old drug called Daraprim in August, the company immediately raised the price of one pill from $13.50 to $750. The increase drew protests in the medical community from those concerned that many patients will no longer be able to afford the drug. Don Dahler spoke to Turing CEO Martin Shkreli, who says the move is simply a smart business decision.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.